|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/28 |
| (11) | Number of the document | 2567709 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12188230.2 |
| Date of filing the European patent application | 2008-10-31 | |
| (97) | Date of publication of the European application | 2013-03-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 984827 P | 2007-11-02 | US |
| (72) |
Cong, Feng, US
Rangwala, Shamina M., US
Ettenberg, Seth, US
Guth, Sabine, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |
| Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |